Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHARLES PLIMPTON

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1891777835
CMS profile
267685
Location
PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$3,037.66

8 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $2,296.55 6
Food and Beverage $741.11 2

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $3,037.66 8

Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHARLES PLIMPTON

NPI 1891777835 · CMS profile ID 267685

Allopathic & Osteopathic Physicians / Obstetrics & Gynecology

PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1891777835?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHARLES PLIMPTON, NPI 1891777835, CMS profile ID 267685. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1891777835?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). CHARLES PLIMPTON, NPI 1891777835, CMS profile ID 267685. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1891777835?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
CHARLES PLIMPTON, NPI 1891777835, CMS profile ID 267685, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1891777835?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

8 matching records · $3,037.66 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 8 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–8 of 8.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $578.4611/01/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673851687 CMS
PFIZER INC. $389.3511/01/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673852271 CMS
PFIZER INC. $314.1911/01/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673852273 CMS
PFIZER INC. $86.4011/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673852275 CMS
PFIZER INC. $467.2207/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673030491 CMS
PFIZER INC. $130.4307/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673030499 CMS
PFIZER INC. $654.7107/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673030505 CMS
PFIZER INC. $416.9007/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673030511 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,037.66 8
PY2020 $4,550.00 1
PY2024 $164.80 3
PY2025 $63.56 3

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $280,140.77 30
PY2024 Principal investigator $631,342.46 58
PY2023 Principal investigator $604,319.86 129
PY2022 Principal investigator $1,688,412.68 133
PY2021 Principal investigator $3,601,852.60 159
PY2020 Principal investigator $853,852.30 65
PY2019 Principal investigator $195,210.58 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

65 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $45,675.30 12/17/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742877015
Principal investigator 1 Biohaven Pharmaceuticals, Inc. $3,498.66 12/11/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention No dispute reported 06/30/2026 748986479
Principal investigator 1 PFIZER INC. $110,609.40 12/03/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742877319
Principal investigator 1 PFIZER INC. $10,927.50 12/03/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742897841
Principal investigator 1 SANOFI PASTEUR INC. $1,500.00 11/19/2020 Non-covered Recipient Entity
Medpharmics,LLC
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers No dispute reported 06/30/2026 744020817
Principal investigator 1 GlaxoSmithKline, LLC. $1,875.00 11/18/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734914985
Principal investigator 1 GlaxoSmithKline, LLC. $1,244.00 11/18/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734915623
Principal investigator 1 PFIZER INC. $12,576.30 11/18/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742874183
Principal investigator 1 PFIZER INC. $10,927.50 11/18/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742926161
Principal investigator 1 PFIZER INC. $15,008.40 10/29/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742875277
Principal investigator 1 PFIZER INC. $1,000.00 10/17/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS No dispute reported 06/30/2026 742862653
Principal investigator 1 PFIZER INC. $17,440.50 10/17/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742874187
Principal investigator 1 SANOFI PASTEUR INC. $540.00 10/15/2020 Non-covered Recipient Entity
Medpharmics,LLC
MET42 Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers No dispute reported 06/30/2026 744020781
Principal investigator 1 PFIZER INC. $16,988.40 10/01/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742875275
Principal investigator 1 SANOFI PASTEUR INC. $4,770.00 09/22/2020 Non-covered Recipient Entity
Medpharmics,LLC
MET41 A Randomized Study to Describe the Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers No dispute reported 06/30/2026 744020765
Principal investigator 1 PFIZER INC. $10,108.86 09/19/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742926157
Principal investigator 1 PFIZER INC. $10,600.00 09/18/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS No dispute reported 06/30/2026 742862649
Principal investigator 1 PFIZER INC. $52,773.60 09/18/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742874189
Principal investigator 1 PFIZER INC. $2,500.00 08/29/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742878605
Principal investigator 1 PFIZER INC. $5,639.70 08/19/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742943807
Principal investigator 1 PFIZER INC. $22,800.60 08/06/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742943837
Principal investigator 1 GlaxoSmithKline, LLC. $1,790.10 07/28/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734905865
Principal investigator 1 GlaxoSmithKline, LLC. $1,695.00 07/22/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734911105
Principal investigator 1 PFIZER INC. $475.02 07/15/2020 Non-covered Recipient Entity
MedPharmics
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS No dispute reported 06/30/2026 742860007
Principal investigator 1 PFIZER INC. $62.40 07/15/2020 Non-covered Recipient Entity
MedPharmics
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS No dispute reported 06/30/2026 742862647
Principal investigator 1 GlaxoSmithKline, LLC. $1,790.10 07/02/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734913065
Principal investigator 1 PFIZER INC. $13,500.00 07/02/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742878609
Principal investigator 1 GlaxoSmithKline, LLC. $8,706.60 07/01/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734928645
Principal investigator 1 GlaxoSmithKline, LLC. $200.00 06/17/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734904497
Principal investigator 1 GlaxoSmithKline, LLC. $4,838.40 06/17/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734904615
Principal investigator 1 GlaxoSmithKline, LLC. $1,223.10 06/01/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734904315
Principal investigator 1 GlaxoSmithKline, LLC. $48,782.70 06/01/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734904875
Principal investigator 1 GlaxoSmithKline, LLC. $1,365.00 05/26/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734902073
Principal investigator 1 PFIZER INC. $20,430.30 05/22/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742962761
Principal investigator 1 PFIZER INC. $1,490.28 05/13/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742962757
Principal investigator 1 PFIZER INC. $5,568.00 05/08/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742963003
Principal investigator 1 GlaxoSmithKline, LLC. $1,488.00 05/04/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
RSV MAT-004 No dispute reported 06/30/2026 734902071
Principal investigator 1 PFIZER INC. $4,602.84 05/02/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742963009
Principal investigator 1 PFIZER INC. $9,139.68 04/23/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742962999
Principal investigator 1 PFIZER INC. $45,538.74 04/14/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742963007
Principal investigator 1 GlaxoSmithKline, LLC. $1,351.80 03/27/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525651
Principal investigator 1 GlaxoSmithKline, LLC. $3,610.80 03/27/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525659
Principal investigator 1 GlaxoSmithKline, LLC. $2,703.60 03/25/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525527
Principal investigator 1 GlaxoSmithKline, LLC. $5,833.80 03/25/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525565
Principal investigator 1 GlaxoSmithKline, LLC. $7,547.40 03/25/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525569
Principal investigator 1 GlaxoSmithKline, LLC. $2,597.40 03/25/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525573
Principal investigator 1 GlaxoSmithKline, LLC. $1,708.20 03/18/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525575
Principal investigator 1 PFIZER INC. $8,688.90 03/13/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742962763
Principal investigator 1 GlaxoSmithKline, LLC. $4,546.80 03/11/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525653
Principal investigator 1 PFIZER INC. $24,684.64 03/10/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742962603
Principal investigator 1 GlaxoSmithKline, LLC. $1,123.20 03/04/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525581
Principal investigator 1 GlaxoSmithKline, LLC. $1,708.20 03/04/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525657
Principal investigator 1 PFIZER INC. $3,112.56 02/28/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742980387
Principal investigator 1 GlaxoSmithKline, LLC. $3,195.00 02/25/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525577
Principal investigator 1 GlaxoSmithKline, LLC. $5,026.50 02/25/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525579
Principal investigator 1 GlaxoSmithKline, LLC. $3,739.50 02/25/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525661
Principal investigator 1 PFIZER INC. $45,533.96 02/25/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742980381
Principal investigator 1 GlaxoSmithKline, LLC. $3,598.20 02/19/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525583
Principal investigator 1 GlaxoSmithKline, LLC. $1,708.20 02/19/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525655
Principal investigator 1 GlaxoSmithKline, LLC. $15,381.00 02/12/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525567
Principal investigator 1 GlaxoSmithKline, LLC. $1,351.80 02/05/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525649
Principal investigator 1 PFIZER INC. $41,177.52 02/01/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742980375
Principal investigator 1 GlaxoSmithKline, LLC. $28,852.20 01/23/2020 Non-covered Recipient Entity
MEDPHARMICS LLC
A PHASE II, RANDOMISED, OBSERVER-BLIND, PLACEBO CONTROLLED MULTI-COUNT No dispute reported 06/30/2026 965525571
Principal investigator 1 PFIZER INC. $4,115.10 01/22/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742980341
Principal investigator 1 PFIZER INC. $99,266.04 01/08/2020 Non-covered Recipient Entity
MedPharmics LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742980371